Farmaclair SAS Sustainability Profile
Farmaclair SAS, headquartered in France, is a prominent player in the pharmaceutical and biotechnology industry, specialising in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Founded in 2005, the company has established a strong presence across Europe and beyond, focusing on innovative solutions that cater to the evolving needs of healthcare providers and patients. With a commitment to excellence, Farmaclair SAS offers a diverse range of products, including generic medicines and specialised formulations, distinguished by their rigorous quality standards and compliance with international regulations. The company has achieved significant milestones, positioning itself as a trusted partner in the pharmaceutical supply chain, renowned for its reliability and expertise in complex projects.
DitchCarbon Score
How does Farmaclair SAS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Farmaclair SAS's score of 26 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Farmaclair SAS's reported carbon emissions
Farmaclair SAS, headquartered in France, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is identified as a current subsidiary and does not inherit emissions data from a parent organization. Consequently, there are no specific reduction targets or climate commitments documented, including those from the Science Based Targets initiative (SBTi) or other climate pledges. As a subsidiary, Farmaclair SAS may align with broader industry standards and practices regarding climate commitments, but specific initiatives or targets have not been disclosed. The lack of reported emissions data suggests an opportunity for the company to establish and communicate its climate strategy more effectively, particularly in the context of increasing global emphasis on sustainability and carbon footprint reduction.
How Carbon Intensive is Farmaclair SAS's Industry?
How Carbon Intensive is Farmaclair SAS's Location?
Farmaclair SAS's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Farmaclair SAS has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
